Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women".
作者信息
Goldstein Irwin
出版信息
J Sex Med. 2008 Sep 2;5 Suppl 4:177-8. doi: 10.1111/j.1743-6109.2008.00960.x.
Abstract
摘要
相似文献
1
Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women".
J Sex Med. 2008 Sep 2;5 Suppl 4:177-8. doi: 10.1111/j.1743-6109.2008.00960.x.
2
The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
J Sex Med. 2008 Sep 2;5 Suppl 4:182-93; quiz 193. doi: 10.1111/j.1743-6109.2008.00961.x.
3
Androgens, health and sexuality in women and men.
Maturitas. 2010 Nov;67(3):275-89. doi: 10.1016/j.maturitas.2010.07.011. Epub 2010 Sep 18.
4
Needs assessment.
J Sex Med. 2008 Sep 2;5 Suppl 4:179. doi: 10.1111/j.1743-6109.2008.00962.x.
5
Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
J Sex Med. 2007 Jul;4(4 Pt 1):1001-8. doi: 10.1111/j.1743-6109.2007.00526.x.
6
Placebo response in the treatment of women's sexual dysfunctions: a review and commentary.
J Sex Marital Ther. 2009;35(3):164-81. doi: 10.1080/00926230802716302.
7
Testosterone therapy for sexual dysfunction in postmenopausal women.
Climacteric. 2008 Jun;11(3):181-91. doi: 10.1080/13697130802162822.
8
Testosterone for women: necessary or noxious?
AWHONN Lifelines. 2006 Jun-Jul;10(3):208-9. doi: 10.1111/j.1552-6356.2006.00043.x.
9
Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.
J Sex Med. 2007 Mar;4 Suppl 3:227-34. doi: 10.1111/j.1743-6109.2007.00449.x.
10
The role of androgens in hormone replacement therapy.
Expert Opin Pharmacother. 2005 Sep;6(11):1815-31. doi: 10.1517/14656566.6.11.1815.
Zotero 插件